Bogdanov, AV,
Voloshina, AD,
Sapunova, AS,
Kulik, NV,
Bukharov, SV,
Dobrynin, AB,
Voronina, JK,
Terekhova, NV,
Samorodov, AV,
Pavlov, VN,
Mironov, VF (2022) methicillin-
resistant Staphylococcus aureus (MRSA) strains. The MIC values of all compounds turned out to be 2
Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) in the formation of tumor
resistance to ICIs
drugs and therapy. We performed exosomal miRNA-146a expression
Meshcheryakova, S.,
Shumadalova, A.,
Beylerli, O.,
Gareev, I.,
Zhao, S.,
Wu, J. (2022) The problem of antimicrobial
resistance is an important global public health challenge. We propose
Nasyrova, Regina F.,
Khasanova, Aiperi K.,
Altynbekov, Kuanysh S.,
Asadullin, Azat R.,
Markina, Ekaterina A.,
Gayduk, Arseny J.,
Shipulin, German A.,
Petrova, Marina M.,
Shnayder, Natalia A. (2022) the search for new therapeutic strategies for a disease-modifying therapy for treatment-
resistant Sch (TRS
Asadi-Pooya, AA,
Trinka, E,
Brigo, F,
Hingray, C,
Karakis, I,
Lattanzi, S,
Valente, KD,
Contreras, G,
Turuspekova, ST,
Kishk, NA,
Aljandeel, G,
Farazdaghi, M,
Lopez, YC,
Kissani, N,
Triki, C,
Kramer, G,
Surges, R,
Mesraoua, B,
Yu, HY,
Daza-Restrepo, A,
Alsaadi, T,
Al-Asmi, A,
Kutlubaev, MA,
Pretorius, C,
Jusupova, A,
Khachatryan, SG,
Ranganathan, LN,
Ashkanani, A,
Tomson, T,
Gigineishvili, D (2022) -clonic seizures, or with
drug-resistant epilepsy. The propensity to tell all patients with epilepsy (PWE) about
Pashirova, T.N.,
Shaihutdinova, Z.M.,
Vandyukov, A.E.,
Lyubina, A.P.,
Amerhanova, S.K.,
Voloshina, A.D.,
Samorodov, A.V.,
Souto, E.B.,
Mironov, V.F.,
Mironov, V.F. (2022) activity against methicillin-
resistant strains of S. aureus MRSA-1 and MRSA-2 (MIC = 3.5 and 7.0 µ
Xu, Dongxiao,
Zheng, Bingjie,
Wu, Qiaowei,
Yao, Jinbiao,
Ilyasova, Tatiana,
Beilerli, Aferinc,
Shi, Huaizhang (2022) temporal artery–middle cerebral artery (STA-MCA) anastomosis combined with
multiple burr hole (MBH) surgery
of adaptation to hypoxia and improve the accuracy of
resistance to hypoxia and the prognosis of survival
Background: To examine fundamental characteristics of clinical trials with therapeutic
drug